Fig. 3

Change from baseline to week 4 in mTOQ-6 total score by baseline acute treatment optimization subgroup. Patients were grouped by baseline mTOQ-4 total scores into the following optimization categories: very poor (0), poor (1–5), moderate (6–7), and maximal (8). The mTOQ-6 total score ranges from 6 to 24, with higher scores indicating better acute medication optimization. Epti, eptinezumab (100 mg); mTOQ-4/mTOQ-6, 4-item/6-item Migraine Treatment Optimization Questionnaire